Published today – result of great collaboration between the Gottesman (NCI) and Hourigan (NHLBI) labs at NIH using fantastic dataset generated from BeatAML 1.0 effort.
Congrats to Gege, Blair and our new friends in the Gottesman lab.
The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.
Lab co-author: Katie Lindblad
Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response.
Lab first author: Hong Yuen
Lab co-authors: Katie Lindblad, Sheenu, Greg, Meg, Matt, Nestor, Jingrong, Julie, Blair, Laura and Katie Lai.
MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations.
Lab Co-authors: Hong Yuen, Jingrong, Matt.
Refining AML outcome prediction.
With more to come soon….
27th July 2018
An unexpected pleasure of the lab leaving party was having four generations of lab postbacs all in one place!
In order, from left to right:
Jack Ghannam 2018-Present
Katie Lindblad 2016-2018 (now PhD student, Mt. Sinai)
Matt Mulé 2014-2016 (now MD-PhD student, UNC and OxCam)
Meg Goswami 2012-2014 (now PhD student, GW-NIH)
27th July 2018
Also known as: Katie Lai MD, Christin “Blair” DeStefano MD, Hong Yuen Wong PhD and Katie Lindblad (PhD candidate!). What a great group of people – all of whom live up to our lab motto of “work hard and be nice to people“. Looking forward to updates on their continued success…
2nd June 2016
Pictured (Left to Right):
Hong-Yuen Wong, Qingguo Liu, Matt Mule, Chris Hourigan, Katie Lai, Elena Cho, Meg Goswami, Kary Oetjen and Sheenu Sheela